Bristol Myers Squibb Stock Analysis
BMYMP Stock | USD 1,010 9.00 0.90% |
Bristol Myers Squibb is overvalued with Real Value of 802.3 and Hype Value of 1010.0. The main objective of Bristol-Myers Squibb pink sheet analysis is to determine its intrinsic value, which is an estimate of what Bristol Myers Squibb is worth, separate from its market price. There are two main types of Bristol-Myers Squibb's stock analysis: fundamental analysis and technical analysis.
The Bristol-Myers Squibb pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Bristol-Myers |
Bristol-Myers Pink Sheet Analysis Notes
The company last dividend was issued on the 1st of December 2022. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.The quote for Bristol Myers Squibb is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bristol Myers Squibb please contact the company at 212-546-4000 or go to http://www.bms.com.Bristol Myers Squibb Investment Alerts
Bristol Myers Squibb had very high historical volatility over the last 90 days |
Bristol-Myers Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.11 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol-Myers Squibb's market, we take the total number of its shares issued and multiply it by Bristol-Myers Squibb's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 25th of March, Bristol-Myers Squibb shows the Risk Adjusted Performance of 0.0617, downside deviation of 8.28, and Mean Deviation of 3.47. Bristol Myers Squibb technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bristol Myers Squibb Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bristol-Myers Squibb middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bristol Myers Squibb. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bristol-Myers Squibb Outstanding Bonds
Bristol-Myers Squibb issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bristol Myers Squibb uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bristol-Myers bonds can be classified according to their maturity, which is the date when Bristol Myers Squibb has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
BRISTOL MYERS SQUIBB Corp BondUS110122AB49 | View | |
BRISTOL MYERS SQUIBB Corp BondUS110122BB30 | View | |
BRISTOL MYERS SQUIBB Corp BondUS110122AX68 | View | |
US110122AP35 Corp BondUS110122AP35 | View | |
BRISTOL MYERS SQUIBB Corp BondUS110122AU20 | View | |
BMY 37 15 MAR 52 Corp BondUS110122DW58 | View | |
BMY 39 15 MAR 62 Corp BondUS110122DX32 | View |
Bristol-Myers Squibb Predictive Daily Indicators
Bristol-Myers Squibb intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bristol-Myers Squibb pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | 9.2 T | |||
Rate Of Daily Change | 1.01 | |||
Day Median Price | 1010.0 | |||
Day Typical Price | 1010.0 | |||
Price Action Indicator | 4.5 | |||
Period Momentum Indicator | 9.0 | |||
Relative Strength Index | 64.51 |
Bristol-Myers Squibb Forecast Models
Bristol-Myers Squibb's time-series forecasting models are one of many Bristol-Myers Squibb's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bristol-Myers Squibb's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bristol-Myers Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bristol-Myers Squibb prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bristol-Myers shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bristol-Myers Squibb. By using and applying Bristol-Myers Pink Sheet analysis, traders can create a robust methodology for identifying Bristol-Myers entry and exit points for their positions.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Bristol-Myers Squibb to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.